Heart failure, comorbidities, and polypharmacy among elderly nursing home residents

Polskie Archiwum Medycyny Wewnetrznej

Volumn 123, Issue 4, 2013, Pages 170-175

  Michalik, Cyprian ^a   Matusik, Paweł ^a   Nowak, Jan ^a   Chmielowska, Katarzyna ^a   Tomaszewski, Krzysztof A ^a   Parnicka, Agnieszka ^a   Dubiel, Marzena ^a   Gasowski, Jerzy ^a   Grodzicki, Tomasz ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Comorbidities; Elderly patients; Heart failure; Nursing homes; Polypharmacy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIAC GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE;

AGED; ARTICLE; CHARLSON COMORBIDITY INDEX; CHRONIC DISEASE; COMORBIDITY; FEMALE; HEALTH STATUS; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NURSING HOME; NURSING HOME PATIENT; PHYSICAL EXAMINATION; POLYPHARMACY; PREVALENCE;

AGED; AGED, 80 AND OVER; CHRONIC DISEASE; COMORBIDITY; FEMALE; HEART FAILURE; HOMES FOR THE AGED; HUMANS; HYPERTENSION; MALE; MYOCARDIAL ISCHEMIA; NURSING HOMES; POLAND; POLYPHARMACY; PREVALENCE;

EID: 84879648946     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.1682     Document Type: Article

References (34)

1. Korewicki J, Leszek P, Kopacz M. [Epidemiology and current knowledge on the management of heart failure]. In: Dubiel J, Korewicki J, Grodzicki T, eds. [Heart failure]. Via Medica, Gdańsk 2004: 2-18. Polish.
2. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007; 93: 1137-1146.
3. Braunstein JB, Anderson GF, Gerstenblith G, et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol. 2003; 42: 1226-1233.
4. Stewart S, Jenkins A, Buchan S, et al. The current cost of heart failure to the National Health Service in the UK. Eur J Heart Fail. 2002; 4: 361-371.
5. Central Statistical Office. [Demographic Yearbook of Poland 2010]. http://www.stat.gov.pl/cps/rde/xbcr/gus/PUBL-rs-rocznik-demograficzny-2010.pdf. Accessed September, 2012. Polish.
6. Central Statistical Office. [Population prognosis 2003-2030]. http:// www.stat.gov.pl/gus/ 5840-648-PLK-HTML.htm. Accessed September 2012. Polish.
7. Central Statistical Office. [Basic data on health care in 2009]. http:// www.stat.gov.pl/cps/rde/xbcr/gus/PUBL-hsw-basic-data-on-health-care-in-2009.pdf. Accessed September 2012. Polish.
8. Crews DE, Zavotka S. Aging, disability and frailty: implications for universal design. J Physiol Anthropol. 2006; 25: 113-118.
9. Heiat A, Gross CP, Krumholz HM. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med. 2002; 162: 1682-1688.
10. Di Lenarda A, Scherillo M, Maggioni AP, et al. Current presentation and management of heart failure in cardiology and internal medicine hospital units: a tale of two worlds - the TEMISTOCLE study. Am Heart J. 2003; 146: E12.
11. Cruickshank JM. Beta-blockers and heart failure. Indian Heart J. 2010; 62: 101-110.
12. Rutan GH, Hermanson B, Bild DE, et al. Orthostatic hypotension in older adults: the Cardiovascular Health Study. CHS Collaborative Research Group. Hypertension. 1992; 19: 508-519.
13. Hiitola P, Enlund H, Kettunen R, et al. Postural changes in blood pressure and the prevalence of orthostatic hypotension among home-dwelling elderly aged years or older. J Hum Hypertens. 2009; 23: 33-39.
14. Boddaert J, Belmin J. [Orthostatic hypotension and its treatment in the elderly]. Presse Med. 2003; 32: 1707-1715. French.
15. Matusik P, Tomaszewski K, Chmielowska K, et al. [Frequency of frailty syndrome in institutionalized care. Comparison of assessment tools]. Gerontol Pol. 2009; 17: 120-125. Polish.
16. Matusik P, Nowak J, Tomaszewski K, et al. [Hypertension among the elderly on the basis of nursing home residents population]. Pol Przegl Kardiol. 2010; 12: 186-191. Polish.
17. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40: 373-383.
18. Hall WH, Ramachandran R, Narayan S, et al. An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer. 2004; 4: 94.
19. Fedyk-Łukasik M, Zdrojewski T, Wizner B, et al. Heart failure management in Poland: The National Cardiovascular Disease Prevention and Treatment Program POLKARD, edition 2003-2005. Cardiol J. 2007; 14: 552-560.
20. Cleland JG, Cohen-Solal A, Aguilar JC, et al. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet. 2002; 360: 1631-1639.
21. Matusik P, Dubiel M, Wizner B, et al. Age-related gap in the management of heart failure patients. The National Project of Prevention and Treatment of Cardiovascular Diseases - POLKARD. Cardiol J. 2012; 19: 146-152.
22. Kozela M, Szafraniec K, Broda G, et al. Detection and treatment of hypercholesterolemia in primary health care. Pol Arch Med Wewn. 2012; 122: 154-161.
23. Rewiuk K, Wizner B, Fedyk-Łukasik M, et al. Epidemiology and management of coexisting heart failure and atrial fibrillation in an outpatient setting. Pol Arch Med Wewn. 2011; 121: 392-399.
24. McMurray JJV, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012; 33: 1787-1847.
25. Tomaszewski K, Matusik P, Chmielowska K, et al. [Dementia and physical function among elderly residents of chosen care homes]. Gerontol Pol. 2010; 18: 71-75. Polish.
26. Matusik P, Tomaszewski K, Chmielowska K, et al. Severe frailty and cognitive impairment are related to higher mortality in 12-month follow-up of nursing home residents. Arch Gerontol Geriatr. 2012; 55: 22-24.
27. Sielski J, Janion-Sadowska A, Sadowski M, et al. Differences in presentation, treatment, and prognosis in elderly patients with non ST-segment elevation myocardial infarction. Pol Arch Med Wewn. 2012; 122: 253-261.
28. Zawilska K, Podolak-Dawidziak M. Therapeutic problems in elderly patients with hemophilia. Pol Arch Med Wewn. 2012; 122: 567-576.
29. Szymik M, Szyguła-Jurkiewicz B, Partyka R, et al. Three-year survival of patients with chronic systolic heart failure due to hypertension: analysis of prognostic factors. Pol Arch Med Wewn. 2012; 122: 543-550.
30. Fedarko NS. The biology of aging and frailty. Clin Geriatr Med. 2011; 27: 27-37.
31. Mulero J, Zafrilla P, Martinez-Cacha A. Oxidative stress, frailty and cognitive decline. J Nutr Health Aging. 2011; 15: 756-760.
32. Guzik B, Chwała M, Matusik P, et al. Mechanisms of increased vascular superoxide production in human varicose veins. Pol Arch Med Wewn. 2011; 121: 279-286.
33. Schramm A, Matusik P, Osmenda G, Guzik TJ. Targeting NADPH oxidases in vascular pharmacology. Vascul Pharmacol. 2012; 56: 216-231.
34. Skalska A, Gałaś A, Grodzicki T. 25-hydroxyvitamin D and physical and cognitive performance in older people with chronic conditions. Pol Arch Med Wewn. 2012; 122: 162-169.